Beam Therapeutics (BEAM) Other Non-Current Assets (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Other Non-Current Assets data on file, last reported at $6.7 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 1.26% year-over-year to $6.7 million in Q1 2026; TTM through Mar 2026 was $6.7 million, a 1.26% increase from a year earlier, with the FY2025 full-year figure at $634000.0, down 49.44% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $6.7 million, up from $634000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for BEAM reached as high as $15.4 million in Q2 2023 and fell as low as $593000.0 in Q3 2025.
• Historically, Other Non-Current Assets has averaged $8.0 million across 5 years, with a median of $6.7 million in 2026.
• Across the five-year window, Other Non-Current Assets climbed 20.99% in 2023 and sank 90.95% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $12.8 million in 2022, then plunged by 31.64% to $8.7 million in 2023, then sank by 85.62% to $1.3 million in 2024, then slumped by 49.44% to $634000.0 in 2025, then soared by 955.68% to $6.7 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $6.7 million in Q1 2026, $634000.0 in Q4 2025, and $593000.0 in Q3 2025.